Bevacizumab in combination with irinotecan and capecitabine as first-line tretment for mCRC-efficacy and safety

Title

Bevacizumab in combination with irinotecan and capecitabine as first-line tretment for mCRC-efficacy and safety

Identifier

/unibl/sci/idNaucniRad:25640
info:doi/https://doi.org/10.1093/annonc/mdu165.175

Type

See all items with this valueConference Paper
See all items with this valuetext

Date

See all items with this value2014

Bibliographic Citation

S. Jungić, G. Kecman-Malčić, I. Rakita, D. Jovanović, R. Gajanin, Z. Marić, B. Tubić, Z. Gojković, Bevacizumab in combination with irinotecan and capecitabine as first-line tretment for mCRC-efficacy and safety, Annals of Oncology, 2014

References

https://www.annalsofoncology.org/article/S0923-7534(19)36202-7/fulltext

presented at

Annals of Oncology

Is Part Of

See all items with this valueAnnals of Oncology

list of authors

See all items with this valueSaša Jungić
See all items with this valueG. Kecman-Malčić
See all items with this valueIvanka Rakita
See all items with this valueD. Jovanović
See all items with this valueRadoslav Gajanin
See all items with this valueZdravko Marić
See all items with this valueBiljana Tubić
See all items with this valueZdenka Gojković

Relation

See all items with this valueMedicinski fakultet

Position: 24278 (31 views)